Murina, F.; Graziottin, A.; Toni, N.; Schettino, M.T.; Bello, L.; Marchi, A.; Del Bravo, B.; Gambini, D.; Tiranini, L.; Nappi, R.E.
Clinical Evidence Regarding Spermidine–Hyaluronate Gel as a Novel Therapeutic Strategy in Vestibulodynia Management. Pharmaceutics 2024, 16, 1448.
https://doi.org/10.3390/pharmaceutics16111448
AMA Style
Murina F, Graziottin A, Toni N, Schettino MT, Bello L, Marchi A, Del Bravo B, Gambini D, Tiranini L, Nappi RE.
Clinical Evidence Regarding Spermidine–Hyaluronate Gel as a Novel Therapeutic Strategy in Vestibulodynia Management. Pharmaceutics. 2024; 16(11):1448.
https://doi.org/10.3390/pharmaceutics16111448
Chicago/Turabian Style
Murina, Filippo, Alessandra Graziottin, Nicla Toni, Maria Teresa Schettino, Luca Bello, Alessandra Marchi, Barbara Del Bravo, Dania Gambini, Lara Tiranini, and Rossella Elena Nappi.
2024. "Clinical Evidence Regarding Spermidine–Hyaluronate Gel as a Novel Therapeutic Strategy in Vestibulodynia Management" Pharmaceutics 16, no. 11: 1448.
https://doi.org/10.3390/pharmaceutics16111448
APA Style
Murina, F., Graziottin, A., Toni, N., Schettino, M. T., Bello, L., Marchi, A., Del Bravo, B., Gambini, D., Tiranini, L., & Nappi, R. E.
(2024). Clinical Evidence Regarding Spermidine–Hyaluronate Gel as a Novel Therapeutic Strategy in Vestibulodynia Management. Pharmaceutics, 16(11), 1448.
https://doi.org/10.3390/pharmaceutics16111448
